GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections with similar results.

Dr. Reddy's, Sun Pharma, Zydus & others launch branded generics after patent expiry, targeting a ₹12,000-crore market ...

Generic semaglutide launches by seven drugmakers, priced 50-80% lower than Novo Nordisk’s original products for diabetes and ...

Add Yahoo as a preferred source to see more of our stories on Google. (Guido Mieth/DigitalVision/Getty Images) We may have a new champion when it comes to pills that can manage both blood sugar levels ...

The MarketWatch News Department was not involved in the creation of this content. -- Average weight loss of 17% if all patients stayed on treatment* with Wegovy(R) (semaglutide) tablets 25 mg (14% ...

Doctors explain the differences between the Wegovy pill and injection in terms of efficacy, side effects, and more. They share how to decide which GLP-1 to take.

Chennai, March 5 -- Highlights: ...

Yes, Wegovy is available in a pill form. Originally, it was only available as a weekly injection, but the Food and Drug Administration (FDA) approved a daily tablet version in December 2025. The ...

An April 10, 2026 PDUFA positions orforglipron to compete with oral semaglutide across diabetes and obesity markets increasingly influenced by direct-to-consumer pricing and evolving access dynamics.

For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...

Chennai (Tamil Nadu), Mar 24 (ANI): The content discusses the discovery and impact of GLP-1 receptor agonists, particularly semaglutide, a hormone-based drug that significantly aids in weight ...

India's drug authority intensifies oversight on generic GLP-1 drugs to prevent misuse and ensure safe distribution and use.